16 insiders have filed at CHE since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Mcnamara Kevin J | President And CEO | 92.2k | 0.674% | 16 sells $19.4M | |
| Hutton Thomas C | Vice President | 32.5k | 0.237% | 1 sells $2.8M | |
| Lee Spencer S | Executive Vice President | 14.9k | 0.109% | 9 sells $6.7M | |
| Rice Thomas P | Director | 6.0k | 0.044% | ||
| Witzeman Michael D | VP & Chief Financial Officer | 6.0k | 0.043% | 1 sells $1.7M | |
| Williams David Patrick | Executive Vice President & CFO | 5.8k | 0.043% | 5 sells $12.2M | |
| Lindell Andrea R | Director | 5.5k | 0.04% | 1 sells $475k | |
| Walsh George J III | Director | 4.0k | 0.029% | 1 buys $83k | 2 sells $355k |
| Grace Patrick P | Director | 3.4k | 0.025% | 2 sells $223k | |
| Judkins Brian C | VP And Chief Legal Officer | 2.4k | 0.018% | 1 buys $75k | 1 sells $7.2M |
| Heaney Christopher J | Director | 2.4k | 0.017% | ||
| Delyons Ron | Director | 1.7k | 0.012% | ||
| Mount John Meredith JR. | Director | 930 | <0.01% | ||
| Mccarthy Eileen P | Director | 855 | <0.01% | ||
| Wherley Joel L | CEO - Vitas Healthcare | 852 | <0.01% | ||
| Westfall Nicholas Michael | Executive Vice President | 3 sells $6.3M |
Full register at boothcheck.com/insiders/CHE. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.